Institutional Ownership Werewolf Therapeutics, Inc. (HOWL)
This table provides information about the institutional ownership of Werewolf Therapeutics, Inc. (HOWL). We have compiled data on the 66 institutions that hold shares in the stock, with a total of 23.6 Million shares, which have been reported (via 13F filing form) to have a value of $30.9 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Edgewood Management LLC
Greenwich, CT |
Aug 13, 2025 Q2 2025 |
50,000
shares
|
$65,500
0.0% of portfolio
|
Q1 2023
New holding
|
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
45,422
shares
|
$59,502
0.0% of portfolio
|
Q2 2025
Reduced 21.86%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2025 Q2 2025 |
44,261
shares
|
$57,981
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Hrt Financial LP
New York, NY |
Aug 14, 2025 Q2 2025 |
42,480
shares
|
$55,648
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Vontobel Holding Ltd.
|
Jul 23, 2025 Q2 2025 |
40,000
shares
|
$52,400
0.0% of portfolio
|
Q2 2025
Added 14.29%
|
|
|
Regal Investment Advisors LLC
Kentwood, MI |
Aug 11, 2025 Q2 2025 |
27,204
shares
|
$35,637
0.0% of portfolio
|
Q4 2024
Added 88.15%
|
|
|
Morgan Stanley
New York, NY |
Aug 15, 2025 Q2 2025 |
27,200
shares
|
$35,632
0.0% of portfolio
|
Q2 2025
Reduced 74.77%
|
|
|
Jain Global LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
26,983
shares
|
$35,347
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Quadrature Capital LTD
London, X0 |
Aug 13, 2025 Q2 2025 |
25,791
shares
|
$33,786
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Two Sigma Securities, LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
22,409
shares
|
$29,355
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Savant Capital, LLC
|
Aug 06, 2025 Q2 2025 |
21,275
shares
|
$27,870
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Point72 Asia (Singapore) Pte. Ltd.
Singapore, U0 |
Aug 14, 2025 Q2 2025 |
20,126
shares
|
$26,365
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
16,012
shares
|
$20,975
0.0% of portfolio
|
Q1 2025
Reduced 74.56%
|
|
|
Camden Capital, LLC
|
Aug 14, 2025 Q2 2025 |
15,000
shares
|
$19,650
0.0% of portfolio
|
Q3 2024
Added 50.0%
|
|
|
Tower Research Capital LLC (Trc)
New York, NY |
Aug 14, 2025 Q2 2025 |
14,377
shares
|
$18,833
0.0% of portfolio
|
Q2 2025
Added 57.26%
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
13,236
shares
|
$17,339
0.0% of portfolio
|
Q2 2025
Reduced 70.82%
|
|
|
Hbk Sorce Advisory LLC
Erie, PA |
Aug 04, 2025 Q2 2025 |
13,227
shares
|
$17,327
0.0% of portfolio
|
Q2 2025
Reduced 2.32%
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Aug 14, 2025 Q2 2025 |
13,044
shares
|
$17,087
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Jump Financial, LLC
Chicago, IL |
Aug 13, 2025 Q2 2025 |
11,345
shares
|
$14,861
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Aug 14, 2025 Q2 2025 |
10,543
shares
|
$13,811
0.0% of portfolio
|
Q2 2025
Added 279.38%
|
|
|
Avantax Advisory Services, Inc.
|
Aug 08, 2025 Q2 2025 |
10,200
shares
|
$13,362
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Larson Financial Group LLC
|
Aug 08, 2025 Q2 2025 |
10,000
shares
|
$13,100
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Highline Wealth Partners LLC
Sherman Oaks, CA |
Jul 16, 2025 Q2 2025 |
10,000
shares
|
$13,100
0.0% of portfolio
|
Q2 2025
New holding
|
|
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
Sep 04, 2025 Q2 2025 |
9,625
shares
|
$12,608
0.0% of portfolio
|
Q4 2024
Reduced 10.91%
|
|
|
Cwm, LLC
|
Jul 25, 2025 Q2 2025 |
8,448
shares
|
$11,066
0.0% of portfolio
|
Q2 2025
Added 24.51%
|